We are pleased to announce that Anja Bührer Head of Regulatory Affairs and Cordula Landgraf Head of Public Affairs and Regulatory Policy will present a free webinar entitled “Revised Swiss Therapeutic Products Act & Ordinances” (28 November, 2019, 4 to 5 pm CEST). The webinar, moderated by CEO Shayesteh Fürst-Ladani, will provide an overview of the revisions, the opportunities that these changes have presented for certain medicinal product categories and the implications for drug safety and transparency. Specific topics will include Article 13, simplified and temporary marketing authorization, orphan drugs and data protection, pediatric investigation plans, and the SwissPAR.

Register now to take advantage of the expert insights provided by the SFL team on this important topic and find out how the revisions could affect your products on the Swiss market. More information and a link for registration can be found here.

SFL provides strategic and operational support for regulatory, quality, as well as commercial projects, including pre- and post-launch activities, analysis of markets and healthcare professional (HCP) target groups and the establishment or maintenance of supply chains.